Chronic Lyme Disease: Complementary Approaches as Adjuncts to Standard Care

Disclaimer: These strategies are adjunctive only. Evidence-based antibiotic therapy per IDSA guidelines remains the cornerstone for active Borrelia burgdorferi infection. "Chronic Lyme" is a contested term; persistent symptoms post-treatment may reflect post-treatment Lyme disease syndrome (PTLDS), autoimmunity, or other diagnoses.

Potential Adjunctive Supports (Limited Evidence)

  • Herbal antimicrobials: Cat's claw (Uncaria tomentosa), Japanese knotweed (Polygonum cuspidatum), andrographis, cryptolepis — in vitro anti-Borrelia activity; human data sparse.
  • Immune-supportive nutrients: Vitamin D (optimize >40 ng/mL), C, zinc, magnesium, omega-3s.
  • Anti-inflammatory diet: Mediterranean pattern, low processed sugar, high polyphenols.
  • Gut microbiome support: Probiotics (multi-strain), prebiotics — mitigate antibiotic-associated dysbiosis.
  • Lifestyle: Paced activity (avoid boom-bust), sleep hygiene, stress reduction (meditation, yoga, HRV biofeedback).

Standard Antibiotic Regimens (IDSA)

  • Early localized: Doxycycline 100 mg BID × 10–14 days.
  • Early disseminated / neurologic: Ceftriaxone 2 g IV daily × 14–28 days.
  • Late arthritis: Doxycycline × 28 days or ceftriaxone × 14–28 days.

Multidisciplinary Approach

Persistent symptoms warrant evaluation by infectious disease, rheumatology, neurology, and pain management. Functional medicine integration should be coordinated, not fragmented.

Lyme Disease - Related Articles